Ripasudil Eye Drops for Cataract Surgery
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests K-321 to see if it helps people recover better after cataract surgery. It focuses on ensuring the treatment is safe and effective for these patients.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. Please consult with the study team for guidance.
How is Ripasudil eye drops unique for cataract surgery?
Ripasudil eye drops are unique because they are being explored specifically for use in cataract surgery, which is different from other treatments that focus on post-operative discomfort or dry eye relief. This suggests a novel application of Ripasudil, potentially offering benefits during the surgical process itself, unlike other eye drops that are typically used after surgery.12345
Who Is on the Research Team?
Shona Pendse, MD, MMSc
Principal Investigator
Kowa Pharma Development Co.
Are You a Good Fit for This Trial?
Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive K-321 or placebo ophthalmic solution four times daily for 12 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment
Extension
Participants in some groups undergo an extended follow-up period
What Are the Treatments Tested in This Trial?
Interventions
- Placebo
- Ripasudil
Find a Clinic Near You
Who Is Running the Clinical Trial?
Kowa Research Institute, Inc.
Lead Sponsor